Sotrovimab: The first monoclonal antibody active against all SARS-CoV-2 variants of concern
The Evolution of the Medical Affairs Function
tranScrip’s Sustainability Commitments
World Diabetes Day
Development Milestone: Synairgen announces patient recruitment completion of their Phase 3 COVID-19 Study
tranScrip’s Outgoing Managing Partner becomes President of the Faculty of Pharmaceutical Medicine
tranScrip is thriving
tranScrip announces appointment of Marcin Mankowski as the new Managing Partner